Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

British Journal of Cancer
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. british journal of cancer
  3. regular article
  4. article
Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer
Download PDF
Download PDF
  • Regular Article
  • Open access
  • Published: 04 July 2000

Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer

  • R Jin1,
  • B H Bay1,
  • V T K Chow2,
  • P H Tan3 &
  • …
  • V C L Lin4 

British Journal of Cancer volume 83, pages 319–323 (2000)Cite this article

  • 1014 Accesses

  • 37 Citations

  • Metrics details

This article has been updated

Abstract

Metallothioneins (MTs), a group of ubiquitous metalloproteins, comprise isoforms encoded by ten functional genes in humans. Different MT isoforms possibly play different functional roles during development or under various physiological conditions. The MT-1E isoform mRNA has been recently shown to be differentially expressed in oestrogen receptor (OR)-positive and OR-negative breast cancer cell lines. In this study, we evaluated MT-1E mRNA expression via semi-quantitative RT-PCR in 51 primary invasive ductal breast cancer tissues, concurrently with OR-positive and progesterone receptor (PR)-positive MCF7 cells, OR-negative and PR-negative MDA-MB-231 cells and PR-transfected MDA-MB-231 breast cancer cells (ABC28). We demonstrated significantly higher MT-1E mRNA expression in OR-negative compared with OR-positive breast cancer tissues (P= 0.026). MCF7 cells lacked MT-1E mRNA expression, while both OR- and PR-negative MDA-MD-231 cells exhibited a high level of MT-1E mRNA expression. The level of MT-1E mRNA expression in progesterone-treated and -untreated ABC28 cells remained similar as the parental cell line MDA-MB-231-C2 cells. The results suggest that MT-1E may have specific and functional roles in OR-negative invasive ductal breast cancers, possibly mediated via effector genes downstream of the oestrogen receptor, but not through the PR pathway. © 2000 Cancer Research Campaign

Similar content being viewed by others

LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer

Article Open access 08 February 2025

In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPER

Article Open access 20 October 2023

mRNA ratios of AR to ESR1 and PGR distinguish breast cancer subtypes based on public datasets and experimental models

Article Open access 01 July 2025

Article PDF

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  • Abdel-Mageed AB and Agrawal KC (1997) Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4: 199–207.

    CAS  PubMed  Google Scholar 

  • Andrews GK, Huet-Hudson YM, Paria BC, McMaster MT, De SK and Dey SK (1991) Metallothionein gene expression and metal regulation during preimplantation mouse embryo development (MT mRNA during early development). Dev Biol 145: 13–27.

    Article  CAS  Google Scholar 

  • Cavigelli M, Kagi JHR and Hunziker PE (1993) Cell- and inducer-specific accretion of human isometallothioneins. Biochem J 292: 551–554.

    Article  CAS  Google Scholar 

  • Celentano E, Montella M, Bonelli P, Cecco L, Marco MD, Botti G and D’Aiuto G (1998) Does a relationship exist between trends in oestrogen receptor levels and breast cancer incidence and mortality?. Int J Oncol 13: 129–135.

    CAS  PubMed  Google Scholar 

  • Dowsett M (1998) Improved prognosis for biomarkers in breast cancer. Lancet 351: 1753–1754.

    Article  CAS  Google Scholar 

  • Elston CW and Ellis IO (1998). Systemic Pathology, Vol 13, The Breast, 3rd edn Churchill Livingstone: Edinburgh

    Google Scholar 

  • Fresno M, Wu W, Rodriguez JM and Nadji M (1993) Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Archiv A Pathol Anat Histopathol 423: 215–219.

    Article  CAS  Google Scholar 

  • Friedline JA, Garrett SH, Somji S, Todd JH and Sens DA (1998) Differential expression of the MT-1E gene in oestrogen-receptor-positive and -negative human breast cancer cell lines. Am J Pathol 152: 23–27.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Goulding H, Jasani B, Pereira H, Reid A, Galea M, Bell JA, Elston CW, Robertson JF, Blamey RW, Nicholson RA, Schmid KW and Ellis IO (1995) Metallothionein expression in human breast cancer. Br J Cancer 72: 968–972.

    Article  CAS  Google Scholar 

  • Haerslev T, Jacobsen GK and Zedeler, (1995) The prognostic significance of immunohistochemically detectable metallothionein in primary breast carcinomas. APMIS 103: 279–285.

    Article  CAS  Google Scholar 

  • Jahroudi N, Foster R, Price-Haughey J, Beitel G and Gedamu L (1990) Cell-type specific and differential regulation of the human metallothionein genes. J Biol Chem 265: 6506–6511.

    CAS  PubMed  Google Scholar 

  • Jasani B, Campbell F, Navabi H, Schmid KW and Williams GT (1998) Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. J Pathol 184: 144–147.

    Article  CAS  Google Scholar 

  • Jayasurya A, Bay BH, Yap WM and Tan NG (2000) Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer 82: 1198–1203.

    Article  CAS  Google Scholar 

  • Jin R, Bay B, Tan P and Tan BK (1999) Metallothionein expression and zinc levels in invasive ductal breast carcinoma. Oncol Rep 6: 871–875.

    CAS  PubMed  Google Scholar 

  • Kagi JHR and Schaffer A (1988) Biochemistry of metallothionein. Biochemistry 27: 8509–8515.

    Article  CAS  Google Scholar 

  • Kagi JHR (1991) Overview of metallothioneins. Methods Enzymol 205: 613–626.

    Article  CAS  Google Scholar 

  • Karin M, Eddy RL, Henry WM, Haley LL, Byers MG and Shows TB (1984) Human metallothionein genes are clustered on chromosome 16. Proc Natl Acad Sci USA 81: 5494–5498.

    Article  CAS  Google Scholar 

  • Kondo Y, Kuo SM, Watkins SC and Lazo JS (1995) Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumour cell lines. Cancer Res 55: 474–477.

    CAS  PubMed  Google Scholar 

  • Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Chan VSW and Ho GH (1999) Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. Clin Cancer Res 5: 395–403.

    CAS  PubMed  Google Scholar 

  • Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL and Bay BH (2000) Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor cDNA. Mol Endocrinol 14: 348–358.

    Article  CAS  Google Scholar 

  • Lohrer H and Robson T (1989) Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents. Carcinogenesis 10: 2279–2284.

    Article  CAS  Google Scholar 

  • McCluggage WG, Maxwell P, Hamilton PW and Jasani B (1999) High metallothionein expression is associated with features predictive of aggrfessive behaviour in endometrial carcinoma. Histopathology 34: 51–55.

    Article  CAS  Google Scholar 

  • Mckenzie K and Sukumar S (1996) Molecular genetics of human breast cancer. Cellular and Molecular Mechanisms of Hormonal Carcinogenesis Huff J, Boyd J, Barrett J C (eds) pp 183–209, Wiley-Liss: New York

    Google Scholar 

  • Mididoddi S, McGuirt JP, Sens MA, Todd JH and Sens DA (1996) Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett 685: 17–27.

    Article  Google Scholar 

  • Murphy LC, Dotzlaw H, Leygue E, Coutts A and Watson P (1998) The pathophysiological role of oestrogen receptor variants in human breast cancer. J Steroid Biochem Molec Biol 65: 175–180.

    Article  CAS  Google Scholar 

  • Palmiter RD, Findley SD, Whitmore TE and Durnam DM (1992) MT-III, a brain-specific member of the metallothionein gene family. Proc Natl Acad Sci USA 89: 6333–6337.

    Article  CAS  Google Scholar 

  • Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, Zambrowicz BP and Palmiter RD (1994) Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33: 7250–7259.

    Article  CAS  Google Scholar 

  • Rayter Z (1991) Steroid receptors in breast cancer. Br J Surg 78: 528–535.

    Article  CAS  Google Scholar 

  • Richards RI, Heguy A and Karin M (1984) Structural and functional analysis of the human metallothionein-1A gene: differential induction by metal ions and glucocorticoids. Cell 37: 263–272.

    Article  CAS  Google Scholar 

  • Rich MA, Furmanski P and Brooks SC (1978) Prognostic value of oestrogen receptor determinations in patients with breast cancer. Cancer Res 38: 4296–4298.

    CAS  PubMed  Google Scholar 

  • Schmid KW, Ellis IO, Gee JMW, Darke BM, Lees WE, Kay J, Cryer A, Stark JM, Hittmair A, Ofner Dunser M, Margreiter R, Daxenhichler G, Nicholson RI, Bier B, Bocker W and Jasani B (1993) Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Archiv A Pathol Anat Histopathol 422: 153–159.

    Article  CAS  Google Scholar 

  • Schmidt CJ and Hamer DH (1986) Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci USA 83: 3346–3350.

    Article  CAS  Google Scholar 

  • Stennard FA, Holloway AF, Hamilton J and West AK (1994) Characterization of six additional human metallothionein genes. Biochim Biophys Acta 1218: 357–365.

    Article  CAS  Google Scholar 

  • West AK, Stallings R, Hildebrand CE, Chiu R, Karin M and Richards RI (1990) Human metallothionein genes: structure of the functional locus at 16q13. Genomics 8: 513–518.

    Article  CAS  Google Scholar 

  • Wittliff JL, Pasic R and Bland KI (1998) Steroid and peptide hormone receptors: methods, quality control and clinical use. The Breast 1: Bland K I, Copeland E M (eds) pp 458–498, WB Saunders Co: Philadelphia

    Google Scholar 

  • Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N and Lazo JS (1994) Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cells. Mol Pharmacol 45: 453–460.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy, Kent Ridge, S119260

    R Jin & B H Bay

  2. Department of Microbiology, Faculty of Medicine, National University of Singapore, Kent Ridge, S119260

    V T K Chow

  3. Department of Pathology, Outram Road, S169608, Republic of Singapore

    P H Tan

  4. Department of Clinical Research, Singapore General Hospital, Outram Road, S169608, Republic of Singapore

    V C L Lin

Authors
  1. R Jin
    View author publications

    Search author on:PubMed Google Scholar

  2. B H Bay
    View author publications

    Search author on:PubMed Google Scholar

  3. V T K Chow
    View author publications

    Search author on:PubMed Google Scholar

  4. P H Tan
    View author publications

    Search author on:PubMed Google Scholar

  5. V C L Lin
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

About this article

Cite this article

Jin, R., Bay, B., Chow, V. et al. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer. Br J Cancer 83, 319–323 (2000). https://doi.org/10.1054/bjoc.2000.1276

Download citation

  • Received: 23 December 1999

  • Revised: 29 March 2000

  • Accepted: 10 April 2000

  • Published: 04 July 2000

  • Issue date: 01 August 2000

  • DOI: https://doi.org/10.1054/bjoc.2000.1276

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • breast cancer
  • metallothionein 1E isoform
  • RT-PCR
  • oestrogen receptor
  • progesterone receptor

This article is cited by

  • The roles of metallothioneins in carcinogenesis

    • Manfei Si
    • Jinghe Lang

    Journal of Hematology & Oncology (2018)

  • The unique C- and N-terminal sequences of Metallothionein isoform 3 mediate growth inhibition and Vectorial active transport in MCF-7 cells

    • Brent Voels
    • Liping Wang
    • Seema Somji

    BMC Cancer (2017)

  • Expression of metallothionein protein relating to proliferative cell index in malignant feline mammary tumors using high throughput tissue microarray technique

    • Anudep Rungsipipat
    • Panchan Sitthicharoenchai
    • Sirikachon Tangkawattana

    Comparative Clinical Pathology (2016)

  • Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration

    • Y Wu
    • M S Siadaty
    • D Theodorescu

    Oncogene (2008)

  • Clinicopathological significance of metallothioneins in breast cancer

    • Rongxian Jin
    • Jingxiang Huang
    • Boon-Huat Bay

    Pathology & Oncology Research (2004)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open access publishing
  • About the Editors
  • Contact
  • Special Issues
  • For Advertisers
  • Subscribe

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

British Journal of Cancer (Br J Cancer)

ISSN 1532-1827 (online)

ISSN 0007-0920 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited